These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16362794)

  • 1. Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.
    Prete M; Perosa F; Favoino E; Dammacco F
    Clin Exp Med; 2005 Dec; 5(4):141-60. PubMed ID: 16362794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in the immunotherapy of autoimmune diseases.
    Perosa F; Luccarelli G; Prete M; Dammacco F
    Ann Ital Med Int; 2001; 16(4):220-32. PubMed ID: 11799630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential target of infliximab in autoimmune and inflammatory diseases.
    Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
    Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological response modifiers in the treatment of immunoinflammatory diseases].
    Skov L; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2120-6. PubMed ID: 18565292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in the treatment of lung cancer.
    Egri G; Takáts A
    Eur J Surg Oncol; 2006 May; 32(4):385-94. PubMed ID: 16504454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on therapeutic monoclonal antibodies.
    Bussel JB; Giulino L; Lee S; Patel VL; Sandborg C; Stiehm ER
    Curr Probl Pediatr Adolesc Health Care; 2007 Apr; 37(4):118-35. PubMed ID: 17434008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New methods of therapy for ocular inflammatory autoimmune diseases].
    Kubicka-Trzaska A; Undas A
    Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system].
    Aldea JJ
    Neurologia; 2012 Jan; 27(1):39-45. PubMed ID: 21481980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cells move to centre stage: novel opportunities for autoimmune disease treatment.
    Browning JL
    Nat Rev Drug Discov; 2006 Jul; 5(7):564-76. PubMed ID: 16816838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
    Cvetkovic I; Stosic-Grujicic S
    Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.